XTANDI
Identification of Xtandi
| No description |
Google image searchProduct monograph
Active ingredient
enzalutamide, 40 MG
DIN: 02407329
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: ASTELLAS PHARMA CANADA INC
Date: 07-JUN-2013
ATC:
- L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
- L02B — HORMONE ANTAGONISTS AND RELATED AGENTS (ATC, ATC/DDD)
- L02BB — Anti-androgens (ATC, ATC/DDD)
- L02BB04 — ENZALUTAMIDE (ATC/DDD)
